The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.15
Bid: 27.90
Ask: 28.10
Change: 0.45 (1.62%)
Spread: 0.20 (0.717%)
Open: 28.00
High: 28.50
Low: 27.65
Prev. Close: 27.70
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE plc: First commercially available 200mm VCSEL

11 May 2022 07:00

RNS Number : 0209L
IQE PLC
11 May 2022
 

IQE plc

Cardiff, UK

11 May 2022

 

Reach

 

 

IQE announces the world's first commercially available 200 mm (8") VCSEL wafer

 

· Enables the expansion of the 3D sensing market beyond the smartphone

· Based on IQE's patented 200mm technology for Wireless and Photonics compound semiconductor applications

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, is pleased to announce the world's first commercially available 200 mm (8") VCSEL epiwafer.

IQE is leading the compound semiconductor industry in the development of 200mm epiwafers for wireless, sensing and display markets.

IQE's 200mm epiwafers will enable a step-change in unit economics for compound semiconductors, leading to the expansion of the market for IQE. The increase in wafer size will expand to new foundry partnerships, including Silicon-based foundries. Furthermore, it enables the integration of compound semiconductors on silicon, allowing adoption across a wider range of devices and applications.

IQE's 200mm VCSEL development is an example of the Company's continued innovation with the aim of expanding the market for wireless and 3D Sensing. 3D Sensing was made economical within premium smartphones in 2017 when IQE developed and scaled VCSEL epiwafers from 100mm to 150mm. The introduction of 200mm creates opportunities beyond the smartphone, into a broad range of intelligent connected devices and also enabling applications in the Metaverse.

Americo Lemos, Chief Executive Officer of IQE, commented:

"This is a critical milestone and establishes IQE as the global leader in scaling compound semiconductor technology to larger diameters. As we set out in our FY21 Results in March, a key focus area is growing our business by extending our roadmap to 200mm to establish new foundry partnerships. This advancement will expand the market for both Wireless and Photonics applications and service the growing demand for compound semiconductors as macro trends such as 5G and the Metaverse proliferate and capture more value for our technology."

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Tim Pullen

Amy Barlow

 

Headland Consultancy (Financial PR) + 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Antonia Pollock: +44 (0) 7789 954 356

 

embedded PR (Non-Financial PR)

Europe: Anja-Maria Hastenrath

Phone: +49 89 / 64913634-1

E-mail: ah@embedded-pr.de

 

United States: Cynthia Hoye

Phone: +1 408-858-2602

E-mail: ch@embedded-pr.com

 

ABOUT IQE

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across handset devices, telecoms infrastructure, connected devices and 3D sensing.

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging its intellectual property portfolio including know-how and patents, IQE produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with around 685 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.

 

http://iqep.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADGGDUSBBDGDG
Date   Source Headline
24th Apr 20071:58 pmRNSDirector/PDMR Shareholding
19th Apr 200710:21 amRNSHolding(s) in Company
19th Apr 20078:00 amRNSHolding(s) in Company
13th Apr 20073:16 pmRNSDirector's share options
5th Apr 20073:03 pmRNSDirector/PDMR Shareholding
28th Mar 20077:02 amRNSPreliminary Results
28th Mar 20077:02 amRNSRe Contract
20th Mar 200711:49 amRNSHolding(s) in Company
5th Mar 20079:25 amRNSHolding(s) in Company
22nd Feb 20073:05 pmRNSNotice of Results
14th Feb 20072:35 pmRNSHolding(s) in Company
14th Feb 20072:22 pmRNSHolding(s) in Company
12th Feb 20075:38 pmRNSHolding(s) in Company
6th Feb 20075:14 pmRNSHolding(s) in Company
5th Feb 200712:36 pmRNSHolding(s) in Company
26th Jan 200710:50 amRNSHolding(s) in Company
18th Jan 20071:35 pmRNSAdditional Listing
9th Jan 20073:12 pmRNSAdditional Listing
9th Jan 20073:10 pmRNSDirector/PDMR Shareholding
9th Jan 200710:04 amRNSDirectorate Change
8th Jan 20077:00 amRNSAcquisition Completion
28th Dec 20067:00 amRNSTotal Voting Rights
22nd Dec 20069:55 amRNSDirector/PDMR Shareholding
22nd Dec 20067:38 amRNSTrading Statement
22nd Dec 20067:38 amRNSAcquisition
1st Dec 20062:36 pmRNSHolding(s) in Company
24th Nov 20067:01 amRNSMore Industry Recognition
20th Nov 20063:39 pmRNSAdditional Listing
13th Nov 200611:35 amRNSDirector/PDMR Shareholding
10th Nov 20062:58 pmRNSHolding(s) in Company
10th Nov 20062:48 pmRNSHolding(s) in Company
24th Oct 20065:25 pmRNSHolding(s) in Company
18th Oct 20069:11 amRNSSupplier Agreement
18th Oct 20067:01 amRNSSupplier Agreement
30th Aug 20063:27 pmRNSAdditional Listing
30th Aug 20067:02 amRNSInterim Results
25th Aug 20063:06 pmRNSHolding(s) in Company
25th Aug 20063:04 pmRNSHolding(s) in Company
25th Aug 20069:30 amRNSHolding(s) in Company
22nd Aug 200611:20 amRNSHolding(s) in Company
21st Aug 20064:57 pmRNSHolding(s) in Company
21st Aug 20067:00 amRNSAcquisition
18th Aug 20062:54 pmRNSHolding(s) in Company
18th Aug 20062:52 pmRNSHolding(s) in Company
18th Aug 200612:36 pmRNSHolding(s) in Company
15th Aug 20065:27 pmRNSHolding(s) in Company
15th Aug 200611:17 amRNSEGM Statement
10th Aug 200610:09 amRNSIssue of Equity
2nd Aug 200611:21 amRNSHolding(s) in Company
31st Jul 20064:07 pmRNSDirectors' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.